King Pfizer Drug Patent Portfolio
King Pfizer owns 1 orange book drug protected by 1 US patent Given below is the list of King Pfizer's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7368469 | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events | 30 Aug, 2020 | Expired |
Latest Legal Activities on King Pfizer's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of King Pfizer.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 Oct, 2019 | US7368469 |
| Post Issue Communication - Certificate of Correction | 25 Jun, 2008 | US7368469 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 06 May, 2008 | US7368469 |
|
Recordation of Patent Grant Mailed
Critical
| 06 May, 2008 | US7368469 |
|
Issue Notification Mailed
Critical
| 16 Apr, 2008 | US7368469 |
| Dispatch to FDC | 31 Mar, 2008 | US7368469 |
| Mail Miscellaneous Communication to Applicant | 26 Mar, 2008 | US7368469 |
|
Application Is Considered Ready for Issue
Critical
| 26 Mar, 2008 | US7368469 |
| Miscellaneous Communication to Applicant - No Action Count | 20 Mar, 2008 | US7368469 |
|
Issue Fee Payment Verified
Critical
| 29 Feb, 2008 | US7368469 |
|
Issue Fee Payment Received
Critical
| 29 Feb, 2008 | US7368469 |
|
Information Disclosure Statement (IDS) Filed
Critical
| 21 Feb, 2008 | US7368469 |
|
Information Disclosure Statement considered
Critical
| 21 Feb, 2008 | US7368469 |
|
Mail Notice of Allowance
Critical
| 15 Jan, 2008 | US7368469 |
| Mail Examiner's Amendment | 15 Jan, 2008 | US7368469 |
King Pfizer's Family Patents
King Pfizer Drug List
Given below is the complete list of King Pfizer's drugs and the patents protecting them.
1. Altace
Altace is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7368469 | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
30 Aug, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Altace's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List